Trial Profile
An Extended Access Program for Perampanel
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Apr 2020
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Expanded access; Therapeutic Use
- Sponsors Eisai Inc
- 10 Apr 2020 Status changed from recruiting to active, no longer recruiting.
- 11 Jun 2013 New trial record